We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Targets – News and Features

News

FEI and Sidec Tackle Validation of Drug Targets

The two companies will collaborate on the commercialization of Protein Tomography solutions.
News

CytRx Announces Publication of Article Discussing Use of RNAi Screening Platform

The Article validates Company's RNAi approach to discovering targets for developing molecular medicines to treat obesity and type 2 diabetes.
News

Broad Partnerships to Enable Maximisation of Opportunities in the Expression Proteomics Sector

Proteomics is divided into protein separation and identification methods, based on its application segments.
News

Varian Acquires Fourier Transform Mass Spectrometry Technology

The acquisition will increase the company's participation in the study of proteins, nucleic acids and drug metabolites.
News

Biofusion Launches Genophrenix Second Spin-out Company

Genophrenix has been formed to capitalise on the discovery of specific proteins.
News

Nanosyn and Amphora Discovery Announce Collaborative Agreement

Nanosyn will provide chemistry-based services to Amphora Discovery for multiple drug targets.
News

Isis-Rosetta Collaborate to Develop Micro-RNA Related Therapies

Research demonstrates therapeutic potential of microRNA as a drug target using antisense.
News

'Metabolomics' is Suited to the Screening of Patients for Clinical Trials

The information garnered through metabolomics will lead to the development of diagnostic tools.
News

Scientists Discover way to fix Drugs with DNA

This is thought to be a crucial step forward for researchers who are developing drugs to combat cancer and other diseases.
News

UMMS Team Uses RNAi to Target Diabetes, Obesity

Researchers report finding proteins that regulate insulin sensitivity and the ability of cells to burn fat.
Advertisement